Fatty liver and pancreatic fat study
Part of Digestive system, Hormones & metabolism clinical trials.
This study looks at people with fatty liver disease to see how fat in the liver relates to fat in the pancreas. It may help understand the condition better and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with fatty liver disease linked to metabolic issues
- You do not drink more than 2 drinks a day (if a woman) or 3 drinks a day (if a man)
- You do not have other liver diseases like hepatitis B or C
- You do not have other serious health problems like cancer, kidney failure, or untreated thyroid issues
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special ultrasound technique (eco-elastography) to measure fat inside the pancreas and see how it relates to metabolic syndrome and the cells that produce insulin. It might help understand why some people develop diabetes or other metabolic issues.
This study aims to create a score to measure fat inside the pancreas using imaging. It may help understand how pancreatic fat relates to health conditions.
This study uses scans to measure how common “fatty change” is in the pancreas. It then looks at whether fatty change is related to specific features of pancreatic cysts (and may also include healthy people).
This study looks at whether fat buildup in the pancreas (called pancreatic steatosis) is common in people who have pancreatic cysts or pancreatic cancer. It may help doctors better understand these conditions.
This study checks how often people with Crohn's or ulcerative colitis also have fatty liver disease. It uses a painless scan to measure liver stiffness and fat. If you have IBD, you may join to help researchers learn about the link between these conditions.
This study looks at how the liver's immune environment changes in people with non-alcoholic fatty liver disease (NAFLD) that has progressed to significant scarring. Researchers will use a liver biopsy to understand the inflammation better, which may lead to new treatments.
Hear when a new Exocrine Pancreatic Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.